Alps Advisors Inc Apellis Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

$17.8 Billion
Q3 2025

A detailed history of Alps Advisors Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 62,815 shares of APLS stock, worth $1.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

62,815

Previous 67,761 7.3%

Holding current value

$1.28 Million

Previous $1.17 Million 21.25%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$17.42 - $28.65 $86,159 - $141,702	-4,946 Reduced 7.3%	62,815 $1.42 Million
Q2 2025 Aug 11, 2025	BUY	$16.36 - $23.0 $1.11 Million - $1.56 Million	67,761 New	67,761 $1.17 Million
Q4 2021 Feb 09, 2022	SELL	$30.74 - $49.16 $3.28 Million - $5.24 Million	-106,632 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $31,651 - $70,398	1,008 Added 0.95%	106,632 $3.52 Million
Q2 2021 Aug 11, 2021	SELL	$40.9 - $64.9 $1.28 Million - $2.04 Million	-31,395 Reduced 22.91%	105,624 $6.68 Million

Q1 2021 May 07, 2021	BUY	$40.8 - $57.39 $14,891 - $20,947	365 Added 0.27%	137,019 $5.88 Million
Q4 2020 Feb 03, 2021	BUY	$30.79 - $57.2 $1.24 Million - $2.3 Million	40,239 Added 41.74%	136,654 $7.82 Million
Q3 2020 Nov 04, 2020	SELL	$25.89 - $33.65 $170,822 - $222,022	-6,598 Reduced 6.41%	96,415 $2.91 Million
Q2 2020 Aug 05, 2020	SELL	$24.8 - $38.49 $756,524 - $1.17 Million	-30,505 Reduced 22.85%	103,013 $3.36 Million
Q1 2020 May 06, 2020	BUY	$17.91 - $44.33 $86,362 - $213,759	4,822 Added 3.75%	133,518 $3.58 Million
Q4 2019 Feb 07, 2020	BUY	$22.1 - $30.8 $36,244 - $50,512	1,640 Added 1.29%	128,696 $3.94 Million
Q3 2019 Nov 04, 2019	SELL	$24.09 - $32.18 $127,556 - $170,393	-5,295 Reduced 4.0%	127,056 $3.06 Million
Q2 2019 Aug 07, 2019	SELL	$18.0 - $25.34 $62,946 - $88,613	-3,497 Reduced 2.57%	132,351 $3.35 Million
Q1 2019 May 01, 2019	BUY	$12.81 - $19.82 $75,258 - $116,442	5,875 Added 4.52%	135,848 $2.65 Million
Q4 2018 Feb 04, 2019	BUY	$11.47 - $18.71 $350,523 - $571,777	30,560 Added 30.74%	129,973 $1.71 Million
Q3 2018 Oct 25, 2018	BUY	$16.57 - $21.03 $302,087 - $383,397	18,231 Added 22.46%	99,413 $1.77 Million
Q2 2018 Aug 02, 2018	BUY	$19.63 - $30.0 $1.59 Million - $2.44 Million	81,182 New	81,182 $1.79 Million

Others Institutions Holding APLS

# of Institutions

329

Shares Held

124M

Call Options Held

4.12M

Put Options Held

756K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Apellis Pharmaceuticals, Inc. Transaction History